LAV, Boyu & HongShan Re-up in Gene Therapy Play
09 Aug 2024
US$ 19.00
Lilly Asia Ventures, Boyu Capital, Zoo Capital, HongShan and New Alliance Capital have made a follow-on investment ......
Related Publications
Siguler Guff & Co LP has joined Creador to take an aggregate 10% interest in La Renon Healthcare Pvt Ltd ......
MBK Partners Ltd (MBK) is said to have closed its MBK Partners Fund VI LP at US$5.5 bn, according to various ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.